Effects of replacement fluids used for therapeutic plasma exchange on plasma viscosity and plasma oncotic pressure. 2004

Ibrahim Tek, and Onder Arslan, and Mutlu Arat, and Erol Ayyildiz, and Meltem Tol, and Mehmet Oral, and Osman Ilhan
Ankara University School of Medicine, Ibni Sina Hospital, Department of Medical Oncology, Sihhiye, Ankara, Turkey.

BACKGROUND Apheresis is a procedure in which one of the components of blood is removed. The aim of therapeutic plasma exchange (TPE) is to remove a large fraction of the patient's plasma from the body, and to exchange this with replacement solutions using automatic devices. With this procedure circulating pathogens and toxins are reduced. Before each TPE results of a baseline basal complete blood count, serum protein electrophoresis, coagulation tests and serum electrolytes must be known. The efficacy of this therapy is assessed only by these values. The proteins responsible for disease may be monoclonal proteins, cryoglobulins, lipoproteins, auto or allo antibodies or toxins. In this study, we aimed to compare the effects of several replacement fluids on plasma viscosity and oncotic pressure. At the same time, we evaluated the correlation between plasma viscosity and oncotic pressure. METHODS 111 TPE were performed on 42 patients. Before TPE, the patients whose veins were not suitable were catheterised either by using a subclavian or jugular 11F dialysis catheter. At each session, approximately 1-1.5L of plasma was exchanged. The procedure was performed with albumin in patients whose albumin was under 3gr/dl. Over this value, the exchange fluids were randomised. RESULTS When the overall results were analysed, there was no statistically significant difference between groups 1 (HES+albumin) and group 3 (albumin). The statistical difference between group 2 and 3 was significant, but no difference was observed between group 1 and 2. According to the decreasing plasma viscosity, there was a significant difference between group 2 and group 3, but there was no difference between group 1 and group 2. CONCLUSIONS The replacement solutions used for plasmapheresis are similar when compared for hemorheologic effects, but we have chosen fresh frozen plasma because of fewer side effects.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009997 Osmotic Pressure The pressure required to prevent the passage of solvent through a semipermeable membrane that separates a pure solvent from a solution of the solvent and solute or that separates different concentrations of a solution. It is proportional to the osmolality of the solution. Osmotic Shock,Hypertonic Shock,Hypertonic Stress,Hypotonic Shock,Hypotonic Stress,Osmotic Stress,Hypertonic Shocks,Hypertonic Stresses,Hypotonic Shocks,Hypotonic Stresses,Osmotic Pressures,Osmotic Shocks,Osmotic Stresses,Pressure, Osmotic,Pressures, Osmotic,Shock, Hypertonic,Shock, Hypotonic,Shock, Osmotic,Shocks, Hypertonic,Shocks, Hypotonic,Shocks, Osmotic,Stress, Hypertonic,Stress, Hypotonic,Stress, Osmotic,Stresses, Hypertonic,Stresses, Hypotonic,Stresses, Osmotic
D010951 Plasma Exchange Removal of plasma and replacement with various fluids, e.g., fresh frozen plasma, plasma protein fractions (PPF), albumin preparations, dextran solutions, saline. Used in treatment of autoimmune diseases, immune complex diseases, diseases of excess plasma factors, and other conditions. Exchange, Plasma,Exchanges, Plasma,Plasma Exchanges
D010952 Plasma Substitutes Any liquid used to replace blood plasma, usually a saline solution, often with serum albumins, dextrans or other preparations. These substances do not enhance the oxygen- carrying capacity of blood, but merely replace the volume. They are also used to treat dehydration. Blood Expanders,Plasma Volume Expanders,Expanders, Blood,Expanders, Plasma Volume,Substitutes, Plasma,Volume Expanders, Plasma
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D001809 Blood Viscosity The internal resistance of the BLOOD to shear forces. The in vitro measure of whole blood viscosity is of limited clinical utility because it bears little relationship to the actual viscosity within the circulation, but an increase in the viscosity of circulating blood can contribute to morbidity in patients suffering from disorders such as SICKLE CELL ANEMIA and POLYCYTHEMIA. Blood Viscosities,Viscosities, Blood,Viscosity, Blood
D005260 Female Females
D005440 Fluid Therapy Therapy whose basic objective is to restore the volume and composition of the body fluids to normal with respect to WATER-ELECTROLYTE BALANCE. Fluids may be administered intravenously, orally, by intermittent gavage, or by HYPODERMOCLYSIS. Oral Rehydration Therapy,Rehydration,Rehydration, Oral,Oral Rehydration,Rehydration Therapy, Oral,Therapy, Fluid,Therapy, Oral Rehydration,Fluid Therapies,Oral Rehydration Therapies,Oral Rehydrations,Rehydration Therapies, Oral,Rehydrations,Rehydrations, Oral,Therapies, Fluid,Therapies, Oral Rehydration
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Ibrahim Tek, and Onder Arslan, and Mutlu Arat, and Erol Ayyildiz, and Meltem Tol, and Mehmet Oral, and Osman Ilhan
July 1982, Therapeutische Umschau. Revue therapeutique,
Ibrahim Tek, and Onder Arslan, and Mutlu Arat, and Erol Ayyildiz, and Meltem Tol, and Mehmet Oral, and Osman Ilhan
October 1980, Journal of neurosurgery,
Ibrahim Tek, and Onder Arslan, and Mutlu Arat, and Erol Ayyildiz, and Meltem Tol, and Mehmet Oral, and Osman Ilhan
October 2022, Journal of clinical apheresis,
Ibrahim Tek, and Onder Arslan, and Mutlu Arat, and Erol Ayyildiz, and Meltem Tol, and Mehmet Oral, and Osman Ilhan
January 2005, Nihon rinsho. Japanese journal of clinical medicine,
Ibrahim Tek, and Onder Arslan, and Mutlu Arat, and Erol Ayyildiz, and Meltem Tol, and Mehmet Oral, and Osman Ilhan
June 2015, Deutsche medizinische Wochenschrift (1946),
Ibrahim Tek, and Onder Arslan, and Mutlu Arat, and Erol Ayyildiz, and Meltem Tol, and Mehmet Oral, and Osman Ilhan
September 1978, Surgery, gynecology & obstetrics,
Ibrahim Tek, and Onder Arslan, and Mutlu Arat, and Erol Ayyildiz, and Meltem Tol, and Mehmet Oral, and Osman Ilhan
December 2022, Journal of clinical apheresis,
Ibrahim Tek, and Onder Arslan, and Mutlu Arat, and Erol Ayyildiz, and Meltem Tol, and Mehmet Oral, and Osman Ilhan
May 1993, Acta anaesthesiologica Scandinavica,
Ibrahim Tek, and Onder Arslan, and Mutlu Arat, and Erol Ayyildiz, and Meltem Tol, and Mehmet Oral, and Osman Ilhan
February 2010, Journal of the American Veterinary Medical Association,
Ibrahim Tek, and Onder Arslan, and Mutlu Arat, and Erol Ayyildiz, and Meltem Tol, and Mehmet Oral, and Osman Ilhan
November 1955, Klinische Wochenschrift,
Copied contents to your clipboard!